Microbial profile of burn wounds managed with enzymatic debridement using bromelain-based agent, NexoBrid®

Burns ◽  
2021 ◽  
Author(s):  
Amal Sharaf ◽  
Preetha Muthayya
Burns ◽  
2010 ◽  
Vol 36 (3) ◽  
pp. 352-355 ◽  
Author(s):  
Farhad Hafezi ◽  
Hamid Elmi Rad ◽  
Bijan Naghibzadeh ◽  
AmirHossein Nouhi ◽  
Ghazal Naghibzadeh

2020 ◽  
Vol 41 (6) ◽  
pp. 1224-1230 ◽  
Author(s):  
Seyed Hamid Salehi ◽  
Mahnoush Momeni ◽  
Masoud Vahdani ◽  
Mohammad Moradi

Abstract Burns are a significant public health burden worldwide. In addition to those who die, millions remain with life-threatening deformities and disabilities resulting in stigma and rejection. Surgical excision is currently the standard of care for removing necrotic tissues in burn wounds to prepare the wound bed for grafting or enhancing the healing process. However, there is a growing interest on enzymatic debridement as an adjunct therapy in burn wounds. The aim of this study was to investigate clinical trials using debriding agents for burn wound in humans in a systematic review. This was a systematic review of electronic databases including CINAHL, PubMed, Ovid Medline, Web of Science, Google Scholar, and Embase from January 1969 to February 2019. The study protocol was registered in PROSPERO registry. The following keywords were searched: “burn wounds”, “enzymatic debridement”, “papain”, “papain-urea”, “pine apple”, “Bromelain”, “collagenases”, “Nexobrid”, “Debrase”, “Debridase”, “Actinidia deliciosa”, “Sutilains”, “Debrace”, “piruvat acid”. Those studies fulfilling the inclusion and exclusion criteria with low score of bias based on Cochrane Bias Tool were reviewed. Sixteen investigations fulfilled our inclusion criteria to be reviewed. Six, seven, and three clinical trials on humans were found regarding collagenase, bromelain, and miscellaneous agents. Collagenase has been reported to be effective in burns below 25% of TBSA, especially in outpatients’ clinics. However, Nexobrid has been shown to be effective in deep burns and decreases the percentage of graft without significant adverse effects. There was not enough evidence supporting the clinical values of Papain, Sutilains, Urea, etc. Surgical excision still remains the standard of care for burn wounds debridement. However, enzymatic debridement, especially Bromelain might help to reduce sessions for surgical debridement or area under graft as an adjunct treatment. Despite the fact, more studies with larger sample sizes and with less conflicts of interest are needed to clearly elucidate the exact role of Bromelain.


2013 ◽  
Vol 69 (2) ◽  
pp. 144-150 ◽  
Author(s):  
Vijay Langer ◽  
P.S. Bhandari ◽  
S. Rajagopalan ◽  
M.K. Mukherjee

2021 ◽  
Vol 42 (Supplement_1) ◽  
pp. S125-S126
Author(s):  
Christoph Wallner ◽  
Jana Holtermann ◽  
Marius Drysch ◽  
Johannes Maximilian Wagner ◽  
Mehran Dadras ◽  
...  

Abstract Introduction The optimal therapy for deep burn wounds is based on the principle of rapid necrectomy and coverage in order to achieve healing that is as scar-free as possible. The available infrastructure and the patient’s condition represent limitations. With enzymatic debridement, selective bedside debridement can now be performed, however the optimal cover after enzymatic debridement has not been elucidated to date. In this study we compare superficial dermal and deep dermal wounds, which are either covered with lactic acid membrane, piscine skin, or split-thickness skin graft. To validate our approach the healed burn wounds were examined for objective (elasticity, water content, sebum, wound healing) and subjective skin quality as part of our standard follow-up care. Methods In this study, 12 patients who had received piscine skin, lactic acid membrane, or split-thickness skin graft after enzymatic debridement were retrospectively examined objectively and subjectively for scar quality as part of follow-up care 12 months after the accident. The wound healing process was also documented. Results Acceleration of wound healing was observed with the application of piscine skin vs split-thickness skin graft or lactic acid membrane. Skin elasticity was comparable to that of split-thickness skin graft but significantly better than lactic acid membrane. The sebum production in wounds treated with piscine skin was higher compared to lactic acid membrane covered wounds. The water storage capacity in the piscine skin treated wounds was also significantly higher than in lactic acid membrane or split-thickness skin graft treated wounds. Using the POSAS score, an improvement in elasticity, thickness, pigmentation, and relief was shown in piscine skin treated wounds, as well as a reduction in pain and itching, compared to split-thickness skin graft or lactic acid membrane. Conclusions The use of intact piscine skin immediately following enzymatic debridement in burn wounds results in faster wound healing and better patient outcomes compared to split-thickness skin graft or lactic acid membrane.


1996 ◽  
pp. 97-109
Author(s):  
J. F. Hansbrough ◽  
W. Hansbrough

2020 ◽  
Vol 28 (5) ◽  
pp. 666-675
Author(s):  
Kelly A. A. Kwa ◽  
Ludo Haasterecht ◽  
Anouk Elgersma ◽  
Roelf S. Breederveld ◽  
Marie Louise Groot ◽  
...  

2021 ◽  
Vol 17 (3) ◽  
pp. 207-212
Author(s):  
Hong Sil Joo ◽  
Joo Hoen Choi

Early debridement (i.e., eschar removal) is regarded as a cornerstone for treating burn wounds. Although surgical debridement is the standard method for complete removal of eschars, it has inefficiencies such as blood loss, heat loss, and poor selectivity, the latter of which means that both viable and necrotic tissue are affected. To make up for the shortcomings, various alternative techniques have been developed. Nexobrid, a mixture of proteolytic enzymes with high bromelain content, has emerged as a viable option in recent years due to its selectivity and efficiency. This product enables dissolving eschar without sacrificing viable or healthy tissue, preserving the potential for spontaneous epithelialization, which accelerates wound healing and leads to better aesthetic outcomes in burn wounds. Herein, we present our experience with proteolytic enzyme debridement using Nexobrid.


Sign in / Sign up

Export Citation Format

Share Document